# Hikma Pharmaceuticals USA Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/hikma-pharmaceuticals-usa-inc/646ab738-7dde-4473-abdb-76058836c610

> Inspection records and compliance data for Hikma Pharmaceuticals USA Inc. in Cherry Hill, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Hikma Pharmaceuticals USA Inc.
- FEI Number: 2220525
- City: Cherry Hill
- State: New Jersey
- Country Name: United States
- Address Line 1: 2 Esterbrook Ln
- Zip Code: 08003
- Facility Type: Outsourcing Facility
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK

## Related Documents

- [CRL - Hikma Pharmaceuticals USA Inc. - Unknown Date](https://www.globalkeysolutions.net/records/crl/hikma-pharmaceuticals-usa-inc/830344a3-afdc-4f95-b595-813aa987af98) — source: FDA, date: Invalid Date
- [CRL - Hikma Pharmaceuticals USA Inc. - Unknown Date](https://www.globalkeysolutions.net/records/crl/hikma-pharmaceuticals-usa-inc/ab63be0b-a852-448b-afee-fa7410134f6c) — source: FDA, date: Invalid Date
- [CRL - Hikma Pharmaceuticals USA Inc. - Unknown Date](https://www.globalkeysolutions.net/records/crl/hikma-pharmaceuticals-usa-inc/310294a7-b78f-4218-bb64-f8d5e6ee320c) — source: FDA, date: Invalid Date
- [483 - Hikma Pharmaceuticals USA Inc. - 2024-06-12](https://www.globalkeysolutions.net/records/483/hikma-pharmaceuticals-usa-inc/971b3ca6-91d8-4cb0-8e87-87f250b0d2ab) — source: FDA, date: June 12, 2024
- [FDA Inspection 1237333 - Hikma Pharmaceuticals USA Inc. - 2024-06-12](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/c508334e-3cc5-450a-a665-5fb2a067f1ed) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 12, 2024
- [483 - Hikma Pharmaceuticals USA Inc. - 2023-11-03](https://www.globalkeysolutions.net/records/483/hikma-pharmaceuticals-usa-inc/0d798230-9ea1-4d9b-8d2e-ffbff634ff89) — source: FDA, date: November 3, 2023
- [FDA Inspection 1222115 - Hikma Pharmaceuticals USA Inc. - 2023-11-03](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/e7b030d5-aa1b-472b-8874-97ba0cb35d84) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 3, 2023
- [FDA Inspection 1176451 - Hikma Pharmaceuticals USA Inc. - 2022-07-07](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/fec1c4c9-b369-4a8b-b7d4-95bbcf2bb527) — classification: No Action Indicated (NAI), source: FDA, date: July 7, 2022
- [483 - Hikma Pharmaceuticals USA Inc. - 2019-09-10](https://www.globalkeysolutions.net/records/483/hikma-pharmaceuticals-usa-inc/0c7b12c2-a17c-44fa-946f-a65f1960d2b1) — source: FDA, date: September 10, 2019
- [FDA Inspection 1106822 - Hikma Pharmaceuticals USA Inc. - 2019-09-10](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/607fb2a5-7932-4aff-a16c-1afe2023de82) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 10, 2019
- [FDA Inspection 1067645 - Hikma Pharmaceuticals USA Inc. - 2018-09-14](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/c059d905-bd50-4a5b-89f7-1709212bd9d1) — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2018
- [FDA Inspection 1008043 - Hikma Pharmaceuticals USA Inc. - 2017-04-04](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/a6c8288b-74ed-4ee5-bd8e-f3ccecf3febc) — classification: No Action Indicated (NAI), source: FDA, date: April 4, 2017
- [FDA Inspection 927273 - Hikma Pharmaceuticals USA Inc. - 2015-05-21](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/10ff6e47-fd54-4fc4-9a95-db0119e1d9fa) — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2015
- [FDA Inspection 896197 - Hikma Pharmaceuticals USA Inc. - 2014-09-19](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/8f60a6f5-b134-4607-84d6-64347e66ece2) — classification: No Action Indicated (NAI), source: FDA, date: September 19, 2014
- [FDA Inspection 875193 - Hikma Pharmaceuticals USA Inc. - 2014-05-01](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/a3445219-7569-4463-80b9-92daf76d9f2e) — classification: No Action Indicated (NAI), source: FDA, date: May 1, 2014
- [FDA Inspection 854096 - Hikma Pharmaceuticals USA Inc. - 2013-10-22](https://www.globalkeysolutions.net/records/fda_inspections/hikma-pharmaceuticals-usa-inc/b436c548-702e-4702-b816-71d062d345ca) — classification: No Action Indicated (NAI), source: FDA, date: October 22, 2013

## Related Companies

- [Kindeva Drug Delivery Limited](https://www.globalkeysolutions.net/companies/kindeva-drug-delivery-limited/901e9a7f-5182-43e1-9980-391fca7364b7)
- [Ecolab, Inc.](https://www.globalkeysolutions.net/companies/ecolab-inc/b1f974bf-f8ce-4704-bbe7-2b1cc3d35c03)
- [Western Chemical Inc.](https://www.globalkeysolutions.net/companies/western-chemical-inc/f13bfcbc-06d5-4798-b88f-92e71ffad710)
- [Sandoz GmbH](https://www.globalkeysolutions.net/companies/sandoz-gmbh/02a3eaeb-a765-43ae-873b-93d1d1523696)
- [Cosco International, Inc.](https://www.globalkeysolutions.net/companies/cosco-international-inc/1d902093-955a-4d4e-b6ac-e4deff1773a6)
- [Galephar Pharmaceutical Research Inc.](https://www.globalkeysolutions.net/companies/galephar-pharmaceutical-research-inc/9718f387-543c-4e81-ae61-054ddea9a225)
- [Sovereign Pharmaceuticals, LLC](https://www.globalkeysolutions.net/companies/sovereign-pharmaceuticals-llc/b8432227-cad1-4c55-91cc-a8c613f765fd)
- [Sandoz GmbH](https://www.globalkeysolutions.net/companies/sandoz-gmbh/06a6ffcd-311c-4e6b-8087-573378a1ad87)
- [Frontage Laboratories, Inc.](https://www.globalkeysolutions.net/companies/frontage-laboratories-inc/1705f97d-14a3-4e46-b8a5-220bf2c4799f)
- [Hospira Australia Pty Ltd.](https://www.globalkeysolutions.net/companies/hospira-australia-pty-ltd/43f04346-c63c-4c33-92ed-a42abafdd533)

## Related Officers

- [Yue-Na Blaise](https://www.globalkeysolutions.net/people/yue-na-blaise/d4dc89d1-d9f1-43dc-827b-4e2a53c91cc9)
- [— Jerald Andry, MS](https://www.globalkeysolutions.net/people/jerald-andry-ms/75c94652-2f70-44db-a56f-42444bb662d9)
- [Senior Consumer Safety Officer - Pharmaceutical Quality](https://www.globalkeysolutions.net/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
- [Deputy Director](https://www.globalkeysolutions.net/people/lori-m-newman/a0e448e4-11ba-4095-b879-feabb8750b3f)